Lexaria Receives Conditional Ethics Board Approval for Pilot Human Study Using DehydraTECHTM Technology in Delivering Antiviral Drugs. https://mail.google.com/mail/u/0/#inbox/FMfcgxwJZJQgZSvnDxsDHWGsnBCDLpFB